|
Bermuda
|
98-1343578
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
Suite 1, 3rd Floor
11-12 St. James’s Square
London
SW1Y 4LB
United Kingdom
|
Not Applicable
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
|
☒
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
☐
|
|
|
|
Emerging growth company
|
☐
|
| Item 3. |
Incorporation of Documents by Reference.
|
| (a) |
The Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, filed on May 11, 2021;
|
| (b) |
The information specifically incorporated by reference into the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2021 from the Registrant’s Proxy Statement on Schedule 14A, filed on July 28, 2021;
|
| (c) |
The Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2021, filed on July 28, 2021;
|
| (d) |
The Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2021, filed on October 26, 2021;
|
| (e) |
The Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2021, filed on January 26, 2022;
|
| (f) |
The Registrant’s Current Reports on Form 8-K filed on May 19, 2021, May 26, 2021, June
4, 2021, July 7, 2021, August 12, 2021, November
8, 2021 and March 25, 2022; and
|
| (g) |
The description of the Registrant’s Common Shares contained in the Registrant’s Registration Statement on Form 8-A, filed with the Commission on October 24, 2016 (File
No. 001-37929) under the Exchange Act, including any amendment or report filed for the purpose of updating such description, including Exhibit 4.1 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020,
filed on May 18, 2020.
|
| Item 4. |
Description of Securities
|
| Item 5. |
Interests of Named Experts and Counsel
|
| Item 6. |
Indemnification of Directors and Officers
|
| Item 7. |
Exemption from Registration Claimed.
|
| Item 8. |
Exhibits.
|
|
Incorporated by Reference
|
|||||
|
Exhibit
Number
|
Description of Document
|
Schedule/Form
|
File No.
|
Exhibit
|
Filing Date
|
|
Certificate of Incorporation.
|
S-1
|
333-213891
|
3.1
|
09/30/2016
|
|
|
Memorandum of Association.
|
S-1
|
333-213891
|
3.2
|
09/30/2016
|
|
|
Fifth Amended and Restated Bye-Laws.
|
10-Q
|
001-37929
|
3.3
|
02/10/2020
|
|
|
Description of Common Shares.
|
10-K
|
001-37929
|
4.1
|
05/18/2020
|
|
|
Opinion of Conyers Dill & Pearman Limited as to Legality.
|
|
|
|||
|
Consent of Independent Registered Public Accounting Firm.
|
|
|
|||
|
Consent of Conyers Dill & Pearman Limited (included in Exhibit 5.1).
|
|
|
|||
|
Power of Attorney (included on the signature page to this Registration Statement).
|
|
|
|||
|
2016 Equity Incentive Plan, as amended.
|
S-1
|
333-213891
|
10.5
|
10/20/2016
|
|
|
Forms of Option Grant Notice and Option Agreement under 2016 Equity Incentive Plan, as amended.
|
S-1
|
333-213891
|
10.6
|
09/30/2016
|
|
|
Form of Amendment No.1 to the Stock Option Grant Notice and Option Agreement under 2016 Equity Incentive Plan, as amended.
|
10-Q
|
001-37929
|
10.1
|
11/12/2019
|
|
|
Form of Early Exercise Stock Purchase Agreement under 2016 Equity Incentive Plan, as amended.
|
S-1
|
333-213891
|
10.7
|
09/30/2016
|
|
|
Form of Restricted Stock Unit Grant Notice and Award Agreement under 2016 Equity Incentive Plan, as amended.
|
10-K
|
001-37929
|
10.30
|
05/24/2019
|
|
|
Form of Restricted Stock Unit Grant Notice and Award Agreement under 2016 Equity Incentive Plan, as amended (2019 U.S. Form).
|
10-Q
|
001-37929
|
10.2
|
11/12/2019
|
|
|
Form of Restricted Stock Unit Grant Notice and Award Agreement under 2016 Equity Incentive Plan, as amended (2019 Non-U.S. Form).
|
10-K
|
001-37929
|
10.35
|
05/11/2021
|
|
|
Form of Restricted Stock Award Agreement under 2016 Equity Incentive Plan, as amended.
|
10-K
|
001-37929
|
10.31
|
05/24/2019
|
|
|
2020 Inducement Plan.
|
10-Q
|
001-37929
|
10.5
|
11/12/2020
|
|
|
First Amendment to 2020 Inducement Plan.
|
8-K
|
001-37929
|
10.1
|
03/25/2022
|
|
|
Form of Option Grant Notice and Option Agreement under the 2020 Inducement Plan.
|
10-Q
|
001-37929
|
10.6
|
11/12/2020
|
|
|
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the 2020 Inducement Plan (U.S. Form).
|
10-Q
|
001-37929
|
10.7
|
11/12/2020
|
|
|
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under 2020 Inducement Plan (Non-U.S. Form).
|
10-K
|
001-37929
|
10.40
|
05/11/2021
|
|
|
Filing Fee Table
|
|
Item 9.
|
Undertakings
|
| 1. |
The undersigned Registrant hereby undertakes:
|
|
MYOVANT SCIENCES LTD.
|
||
|
By:
|
/s/ Matthew Lang
|
|
|
Matthew Lang
|
||
|
General Counsel and Corporate Secretary
|
|
Signature
|
Title
|
Date
|
||
|
/s/ David Marek
|
Principal Executive Officer and Director
|
April 8, 2022
|
||
|
David Marek
|
(Principal Executive Officer)
|
|
||
|
/s/ Uneek Mehra
|
Principal Financial Officer
|
April 8, 2022
|
||
|
Uneek Mehra
|
(Principal Financial and Accounting Officer)
|
|
||
|
/s/ Myrtle Potter
|
Chairman and Director
|
April 8, 2022
|
||
|
Myrtle Potter
|
|
|||
|
/s/ Terrie Curran
|
Director
|
April 8, 2022
|
||
|
Terrie Curran
|
|
|||
|
/s/ Mark Guinan
|
Director
|
April 8, 2022
|
||
|
Mark Guinan
|
|
|||
|
/s/ Adele Gulfo
|
Director
|
April 8, 2022
|
||
|
Adele Gulfo
|
|
|||
|
/s/ Hiroshi Nomura
|
Director
|
April 8, 2022
|
||
|
Hiroshi Nomura
|
|
|||
|
/s/ Nancy Valente
|
Director
|
April 8, 2022
|
||
|
Nancy Valente
|